Abstract
In the early 1960s, transplantation was unregulated. As the science of transplantation has progressed, however, laws have evolved, as is the case in almost all areas of science and technology. Regulatory agencies, such as the Organ Procurement and Transplantation Network and Centers for Medicare and Medicaid Services, now exist to provide all patients with access to transplantation without commercialization, to provide quality outcomes for patients, and to ensure that transplant centers and organ-procuring organizations are in alignment with these goals. Today’s health care reform initiatives are focused on quality care and outcomes along with the costs of care. As such, agencies regulating transplantation are closely monitoring transplant centers and organ-procuring organizations to assess quality, to improve performance, and to ensure that they comply with the agencies’ requirements. This chapter summarizes the evolution of these regulatory agencies, the changes currently being made, and their implications for the field of transplantation.
This is a preview of subscription content, log in via an institution to check access.
References
Abecassis MM, Burke R et al (2008) Transplant center regulations-a mixed blessing? An ASTS council viewpoint. Am J Transplant 8:2496–2502
Abecassis MM, Skaro AI et al (2015) Should UNOS and CMS provide regulatory oversight in kidney transplantation? Curr Transplant Rep 2:127–134
Center for Medicare and Medicaid Services Organ Procurement and Transplantation Network Rules and Membership Actions 54 (December 18, 1989) Federal Register 51802
Department of Health and Human Services. Organ Procurement and Transplantation Network (2005) Final Rule. 42 Code of Federal Regulations, Section 121
Hamilton TE (2013) Regulatory oversight in transplantation; are the patients really better off? Curr Opin Organ Transplant 18(2):203–209
Medicare Program (2007) Hospital conditions of participation: requirements for approval and re-approval of transplant centers to perform organ transplants. Federal Register 72(61):15198–15280. Rules and Regulations
National Organ Transplantation Act, Pub. L. 98-607, 98 Stat. 2339 (1984), codified as amended at 42 U.S.C. Section 273–274 (2000)
OPTN Bylaws Appendix L, Section 1.A, Section 6: www.optn.transplant.hrsa.gov/governance/bylaws/. Accessed 9 Sept 2015
OPTN Bylaws Appendix L, Section 15.D www.optn.transplant.hrsa.gov/governance/bylaws/. Accessed 5 Sept 2015
OPTN Bylaws Appendix L, Section 15.E www.optn.transplant.hrsa.gov/governance/bylaws/. Accessed 5 Sept 2015
OPTN Bylaws Appendix L, Section 16 www.optn.transplant.hrsa.gov/governance/bylaws/. Accessed 5 Sept 2015
OPTN Bylaws Appendix L, Section 18 www.optn.transplant.hrsa.gov/governance/bylaws/. Accessed 5 Sept 2015
OPTN Strategic Plan available from www.optn.transplant.hrsa.gov/governance/strategic-plan. Accessed 9 Sept 2015
Social Security Act 42 (1987) United States Code Section 1320b-8(a) (1) (B)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this entry
Cite this entry
Paganafanador, B. (2017). Regulatory Agencies in Transplantation. In: Doria, C. (eds) Contemporary Liver Transplantation. Organ and Tissue Transplantation. Springer, Cham. https://doi.org/10.1007/978-3-319-07209-8_33
Download citation
DOI: https://doi.org/10.1007/978-3-319-07209-8_33
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-07208-1
Online ISBN: 978-3-319-07209-8
eBook Packages: MedicineReference Module Medicine